https://www.selleckchem.com/pr....oducts/napabucasin.h
15-2.24). The DAFI was more prognostic in endometrial (aHR 1.76; 95% CI 1.41-2.18, P0.0001) and vaginal/vulvar (aHR 1.94; 95% CI 1.34-2.81, P=0.0005) cancers as well as patients with loco-regional disease (aHR 1.94; 95% CI 1.62-2.33, P0.0001). Frailty appears to be a significant predictor of mortality in gynecologic cancer patients regardless of chronological age. This measure of functional age may be of particular utility in women with loco-regional disease only who otherwise would have a favorable prognosis. Frailty appear
Like
Comment
Share
